8-K
filed August 21, 2023, 7:59 PM ET
ticker IGC
CIK 0001326205
other
confidence high
sentiment neutral
materiality 0.15
IGC Pharma shareholders pass all five proposals at 2023 annual meeting
IGC Pharma, Inc.
- Claudia Grimaldi elected Class A director with 14.7M for, 1.4M withheld, 11M broker non-votes.
- Ratified Manohar Chowdhry & Associates as auditor for FY2024: 26.9M for, 163K against.
- Approved grant of 3M common shares to employees, advisors, directors; 14.3M for.
- Say-on-pay approved (15.3M for); frequency set at every three years (13.1M for 3 yrs).
- Board adopts triennial advisory vote on executive compensation going forward.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IGC Pharma, Inc. shareholders approved Approve grant of 3,000,000 shares of common stock to employees, advisors, directors, and consultants at the 2023-08-18 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-08-18
Exact text from the filing
For Against Abstain Broker Non-votes 14,268,013 1,861,386 39,115 11,035,662
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IGC Pharma, Inc. shareholders approved Advisory vote on frequency of say-on-pay votes (every three years) at the 2023-08-18 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-08-18
Exact text from the filing
5. Approval to, by a non-binding advisory vote, setting the frequency of say-on-pay votes at future annual meetings of stockholders to every three years; 1 YEAR 2 YEARS 3 YEARS Abstain Broker Non-votes 2,429,382 181,013 13,078,308 479,811 11,035,662
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IGC Pharma, Inc. shareholders approved Election of Director Claudia Grimaldi at the 2023-08-18 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-08-18
Exact text from the filing
1. Election of Directors. Nominee For Withhold Broker Non-votes Claudia Grimaldi 14,740,248 1,428,266 11,035,662
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IGC Pharma, Inc. shareholders approved Advisory approval of compensation of named executive officers at the 2023-08-18 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-08-18
Exact text from the filing
4. Approval of a non-binding advisory resolution to approve the compensation of the Company’s named executive officers. For Against Abstain Broker Non-votes 15,339,051 769,054 60,409 11,035,662
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IGC Pharma, Inc. shareholders approved Ratify appointment of Manohar Chowdhry & Associates as independent registered public accounting firm for 2024 at the 2023-08-18 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-08-18
Exact text from the filing
2. Proposal to ratify the appointment of Manohar Chowdhry & Associates as the Company’s independent registered public accounting firm for the 2024 fiscal year. For Against Abstain 26,949,467 163,043 91,666
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.